VTGN Market Cap & Key Metrics
VistaGen Therapeutics, Inc.
$0.21
-$0.01(-3.82%)
38
Overall
60
Value
18
Tech
36
Quality
Market Cap
$9.17M
Volume
945.49K
52W Range
$0.20 - $1.03
Target Price
$0.97
VTGN market cap is $9.17M. This page lists VistaGen Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
VTGN Key Metrics
- Market cap
- $9.17M
- EPS estimate, current year
- $-1.45
- EPS growth, 3-year
- +40.09%
- Value score
- 60
- Quality score
- 36
- Technical score
- 18
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1.27M | $486.0K | $1.06M | -$227.0K | $1.11M |
| EBITDA | -$71.39M | -$55.33M | -$32.14M | -$58.74M | -$47.05M |
| EPS | $-1.83 | $-1.67 | $-1.52 | $-8.51 | $-7.50 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTGN | $0.21 | -3.8% | 945.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get VistaGen Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW